Hacker News
new
|
past
|
comments
|
ask
|
show
|
jobs
|
submit
login
pas
on Nov 29, 2018
|
parent
|
context
|
favorite
| on:
FDA promised a ‘lower-cost option’ to EpiPen, but ...
Maybe they are in a metastable state, they are not forced to compete and no one is losing market share?
Guidelines
|
FAQ
|
Lists
|
API
|
Security
|
Legal
|
Apply to YC
|
Contact
Search: